检索结果 - Cameron Phillips
- Showing 1 - 4 results of 4
-
1
-
2
Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contem... 由 Cameron Phillips, Ambica Parmar, Helen Guo, Deborah E. Schwartz, Wanrudee Isaranuwatchai, Jaclyn Beca, Wei Fang Dai, Jessica Arias, Scott Gavura, Kelvin Chan
出版 2020Revisão -
3
Experiences of using the Theoretical Domains Framework across diverse clinical environments: a qualitative study 由 Shelley A. Wilkinson, Susie Thomas, Cameron Phillips, Andrea P. Marshall, Nadia J. Chaves, Stacey Jankelowitz, Ivan Lin, Clement T. Loy, Gwyneth Rees, Leanne Sakzewski, The‐Phung To, Susan Michie
出版 2015Artigo -
4
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial 由 James McMahon, Jillian S. Y. Lau, Anna Coldham, Janine Roney, Michelle Hagenauer, Sally Price, Mellissa Bryant, Jill S. Garlick, Anne Paterson, Sue J. Lee, Jess O’Bryan, Anna C. Hearps, Gilda Tachedjian, Henry Pinskier, Cameron Phillips, Stuart Garrow, Nathan Pinskier, Robert Melvin, Luke V. Blakeway, Jessica A. Wisniewski, Sally Byers, Gnei Z. Badoordeen, Stephanie Pereira, Katherine Pragastis, Jason A. Trubiano, Kyra Chua, Marion Kainer, James S. Molton, Bradley J. Gardiner, Anna Pierce, Allen C. Cheng, Benjamin A. Rogers, Anton Y. Peleg
出版 2022Artigo
相关主题
Medicine
Adverse effect
Clinical trial
Environmental health
Internal medicine
Population
Surgery
Alternative medicine
Antibiotic prophylaxis
Antibiotic resistance
Antibiotics
Antimicrobial
Applied psychology
Artificial intelligence
Behaviour change
Biology
Cancer
Clinical endpoint
Computer science
Confidence interval
Coronavirus disease 2019 (COVID-19)
Disease
Economic growth
Economics
Epistemology
Favipiravir
Hazard ratio
Health care
Incidence (geometry)
Infection control